
The new generation toothbrush, which works with piezoelectric polymer technology, destroys bacteria with electrical charges.
AI-generated summary
The research was published in the journal Science Advances and focuses on the use of piezoelectric polymers in oral hygiene.
Peking University researchers have developed a new generation toothbrush that produces electricity only by bending during the brushing movement, without the need for an external battery or charging unit. The findings, details of which were shared in Science Advances, revealed that the new technology was much more successful in eliminating bacteria that cause gum diseases and cavities compared to standard brushes.
While traditional toothbrushes try to clean dental plaque only through mechanical friction, the newly developed brush turns this process into a cleansing at the chemical and biological level. The research team produced brush bristles from polyvinylidene fluoride (PVDF) polymer, which was given "piezoelectric" properties by stretching and heating.
The bristles that bend on the tooth surface during brushing release micro-electric charges that interact with molecules in saliva and produce reactive oxygen species. These electrical charges destroy the cell membranes of harmful bacteria that cause tooth decay and dental inflammation. When the pressure on the bristles is removed, the material absorbs the released loads again.
In 3-month clinical tests conducted with the participation of approximately 100 volunteers, the data of individuals using piezoelectric brushes were compared with the control group using standard nylon brushes. At the end of the process, those who use the new generation brush; A noticeable decrease in dental plaque accumulation, gum inflammation and bleeding was noted.
In the examinations, it was determined that the micro electric current created by the brush did not damage the tooth enamel surface and did not have any toxic effects on human cells.
Evaluating the development, periodontist Dr., one of the experts at the University of Buffalo in New York. Frank Scannapieco stated that the study adds an innovative dimension to an old concept in oral health. Clinical scientist Thomas Flemmig from the University of Hong Kong acknowledged that the material used was highly innovative, but emphasized that the raw values should be detailed so that the data reporting method in the study could be fully compared with other commercial toothbrush studies.
Experts state that long-term safety and cost analyzes must be completed before mass production of this biotechnological product, which does not have a battery and does not constantly release chemicals, unlike other rechargeable or chemical-containing brushes on the market.

Minister of Health Memişoğlu emphasized at the 3rd National Biomedical Congress in Antalya that Türkiye has reached a significant capacity in health services in the last 25 years and should no longer be seen as a market but as a production and innovation center with the vision of 'Productive Health'. He stated that domestic respirators have been exported to 45 countries, important steps have been taken in the development of domestic vaccines and drugs, and it is aimed to start domestic ultrasound production within two years.

The US Food and Drug Administration (FDA) approved the drug called Hibsago, which is used in the treatment of Chronic Hepatitis B and aims to clear the virus with a 6-month injection course. In clinical trials, permanent deletion of the virus was observed in 19% of patients.

University of Virginia School of Medicine Oncology Specialist Dr. Using focused sound waves and nanotechnology, Roger Abounader and his team temporarily opened the blood-brain barrier and suppressed genes that trigger glioblastoma tumor growth with microRNA molecules. Positive results have been obtained in animal models, and clinical trials in humans are being prepared.

WHO Director General Tedros Adhanom Ghebreyesus and Campbell-Lendrum stated that the health agenda in Türkiye will be at the forefront for the COP31 summit. They also spoke with warnings about the Ebola and cholera outbreaks in the Democratic Republic of Congo and the humanitarian crisis in Sudan.

Osaka Metropolitan University researchers examined data from more than 20 thousand people and proved that daily walking reduces health expenses. While the cost decrease was more evident in people over the age of 65, it was determined that the ideal limit was 11 thousand steps per day.

In his statement on the occasion of Organ Donation Week, Minister of Health Kemal Memişoğlu stated that 32 thousand people are waiting for organ transplantation in Türkiye and invited citizens to donate organs via e-Pulse and e-Government.